MRNS Shares Outstanding History
Below is a table of the MRNS shares outstanding history going back to 7/31/2014:

Date MRNS Shares Outstanding
7/31/20143.06M
9/12/20143.48M
11/13/20143.50M
3/12/20153.55M
5/11/20153.56M
8/3/20153.57M
10/29/20153.58M
3/7/20164.88M
4/29/20164.88M
8/8/20164.88M
11/7/20164.93M
3/10/20175.39M
4/28/20175.60M
7/27/20176.52M
10/30/201710.11M
3/5/201810.13M
5/1/201810.13M
8/1/201810.13M
10/26/201810.13M
3/11/201913.13M
4/30/201913.14M
8/7/201913.14M
11/5/201913.47M
3/12/202021.68M
5/1/202021.68M
8/4/202030.55M
9/23/202030.55M
11/5/202030.59M
3/8/202136.58M
5/14/202136.63M

Also see: MRNS Market Cap History
MRNS YTD Return
MRNS Historical Shares Outstanding:
+44.14% CAGR
MRNS Historical Shares Outstanding: +44.14% CAGR

Mouse over chart for data details
7/31/2014 ...5/14/2021
Marinus Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics to treat patients suffering from rare seizure disorders. Co.'s clinical stage product candidate, ganaxolone, is a positive allosteric modulator of gamma-aminobutyric acid (GABAA) being developed in formulations for two different routes of administration: intravenous (IV) and oral. Ganaxolone is a synthetic analog of allopregnanolone, an endogenous neurosteroid. Ganaxolone acts at both synaptic and extrasynaptic GABAA receptors and exhibits anti-seizure, antidepressant and anxiolytic properties. We show 30 historical shares outstanding datapoints in our coverage of MRNS's shares outstanding history.

Understanding the changing numbers of MRNS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MRNS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MRNS by allowing them to research MRNS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for MRNS:
MRNS SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Marinus Pharmaceuticals (MRNS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

MRSN Shares Outstanding History
MRTX Shares Outstanding History
MSON Shares Outstanding History
MTEM Shares Outstanding History
MYGN Shares Outstanding History
MYL Shares Outstanding History
MYND Shares Outstanding History
MYOK Shares Outstanding History
NAOV Shares Outstanding History
NBIX Shares Outstanding History
More Healthcare companies »

 

MRNS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.